The effect of experimental cardiac arrhythmias of a new anticonvulsant agent, Kö 1173, and its comparison with phenytoin and procainamide.
作者信息
Allen J D, Kofi J M, Shanks R G, Zaidi S A
出版信息
Br J Pharmacol. 1970 May;39(1):183P-184P. doi: 10.1111/j.1476-5381.1970.tb09568.x.
Abstract
摘要
相似文献
1
The effect of experimental cardiac arrhythmias of a new anticonvulsant agent, Kö 1173, and its comparison with phenytoin and procainamide.一种新型抗惊厥药Kö 1173对实验性心律失常的作用及其与苯妥英钠和普鲁卡因胺的比较。
Br J Pharmacol. 1970 May;39(1):183P-184P. doi: 10.1111/j.1476-5381.1970.tb09568.x.
2
The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.新型抗惊厥药Kö 1173对实验性心律失常的作用。
Br J Pharmacol. 1972 Aug;45(4):561-73. doi: 10.1111/j.1476-5381.1972.tb08114.x.
3
The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias.二苯妥英（大仑丁）在治疗和预防心律失常方面的临床应用。
Am Heart J. 1969 Mar;77(3):315-23. doi: 10.1016/0002-8703(69)90187-2.
4
The effect of glucagon on arrhythmias due to digitalis toxicity.胰高血糖素对洋地黄毒性所致心律失常的影响。
Am J Cardiol. 1970 Jun;25(6):683-9. doi: 10.1016/0002-9149(70)90619-3.
5
Effect of propranolol, procainamide, and lidocaine on ventricular automaticity and reentry in experimental myocardial infarction.普萘洛尔、普鲁卡因胺和利多卡因对实验性心肌梗死时心室自律性和折返的影响。
Circulation. 1972 Sep;46(3):498-506. doi: 10.1161/01.cir.46.3.498.
6
[Ventricular parasystole: successful treatment with diphenylhydantoin].[室性并行心律：苯妥英钠治疗成功]
G Ital Cardiol. 1972;2(4):575-8.
7
[Proceedings: Clinical pharmacology of anti-arrhythmia agents].[会议论文集：抗心律失常药物的临床药理学]
Med Klin. 1975 Jun 6;70(23):994.
8
[Therapy of arrhythmias].
Wien Z Inn Med. 1973;54(8-9):384-98.
9
[Use and results of treatment with phenytoin infusion concentrate (author's transl)].苯妥英输注浓缩液的使用及治疗结果（作者译）
Dtsch Med Wochenschr. 1974 Oct 4;99(40):1961-4. doi: 10.1055/s-0028-1108075.
10
[Interaction of phenytoin with propranolol, procainamide and digoxin].
Pol Tyg Lek. 1985 Jul 15;40(28):790-3.
引用本文的文献
1
The influence of urinary pH on the elimination of mexiletine.尿液 pH 值对美西律消除的影响。
Br J Clin Pharmacol. 1974 Jun;1(3):229-32. doi: 10.1111/j.1365-2125.1974.tb00241.x.
2
The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.新型抗惊厥药Kö 1173对实验性心律失常的作用。
Br J Pharmacol. 1972 Aug;45(4):561-73. doi: 10.1111/j.1476-5381.1972.tb08114.x.
3
Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173.新型抗心律失常药物Kö 1173作用机制的研究
Br J Pharmacol. 1972 Jan;44(1):1-9. doi: 10.1111/j.1476-5381.1972.tb07232.x.
4
Clinical pharmacological studies of Kö 1173--a new antiarrhythmic agent.新型抗心律失常药物 Kö 1173 的临床药理学研究
Br J Pharmacol. 1973 Mar;47(3):622P-623P.
5
Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.美西律（Kö1173）对犬浦肯野纤维和心室肌的电生理作用。
Br J Pharmacol. 1979 Sep;67(1):143-52.
6
Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.对一种新型抗心律失常药物ORG 6001进行特性研究，包括一项简单的钙拮抗试验。
Br J Pharmacol. 1976 Jun;57(2):251-62. doi: 10.1111/j.1476-5381.1976.tb07475.x.
本文引用的文献
1
SODIUM DIPHENYLHYDANTOIN IN THE TREATMENT OF RECURRENT CARDIAC ARRHYTHMIAS.
JAMA. 1965 Mar 1;191:695-7. doi: 10.1001/jama.1965.03080090009002.
2
Electrophysiological effects of diphenylhydantoin on canine purkinje fibers.苯妥英钠对犬浦肯野纤维的电生理效应。
Circ Res. 1968 Feb;22(2):221-36. doi: 10.1161/01.res.22.2.221.
Zotero 插件